September 25, 2012
Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.
September 30, 2021
In three Science papers, UC San Diego and UC San Francisco researchers mapped out how hundreds of gene mutations involved in cancer affect the discrete groups of proteins that are the ultimate actors behind the disease. The work points the way to identifying new precision treatments.
April 21, 2016
…Panel Advising Biden on Cancer ‘Moonshot’ María Elena Martínez María Elena Martínez was 10 years old when she moved to Chicago from Mexico with her family. Although her parents only had a primary school education, they encouraged her educational pursuits. She went from being an immigrant living in a low-income…
April 8, 2021
An international team of researchers led by computer scientists at the University of California San Diego have identified 163 variable number tandem repeats that actively regulate gene expression. In a Nature Communications paper, the researchers provide new insights into this understudied mechanism
May 2, 2016
Oncternal Therapeutics, a new cancer-focused biotechnology startup, has signed a wide-ranging licensing agreement with UC San Diego to develop and commercialize antibodies and antibody-related binding agents.
April 12, 2023
UC San Diego scientists find a protein associated with liver cancer may actually be the key to protecting against it. By blocking ferroptosis, a form of liver cell death, the protein prevents liver damage and its progression to cancer.
October 10, 2022
More than 100 UC San Diego Health physicians have been named “Top Docs” in the 2022 San Diego Magazine “Physicians of Exceptional Excellence” survey.
January 14, 2022
UC San Diego researchers report successfully removing the nucleus from a type of ubiquitous cell, then using the genetically engineered cell as a unique cargo-carrier to deliver therapeutics precisely to diseased tissues.Researchers at University of California San Diego School of Medicine and Moores
December 12, 2018
UC San Diego researchers join national effort to better understand human immune system as part of new Allen Institute of Immunology.
May 22, 2012
…10, as hundreds of cancer survivors, caregivers, friends and surfers gather together in solidarity in the fight to wipe out cancer. As part of UC San Diego Moores Cancer Center’s 6th annual Survivor Beach, attendees will line surfboards along the shore, nose-to-tail, from Scripps Pier down La Jolla Shores, in…
